期刊文献+

Cover story

Cover story
原文传递
导出
摘要 Successful reprogramming of somatic cells to a pluripotent state can be achieved through the transient expression of defined transcription factors. One of the most exciting aspects of this technology is that human neurons generated from these induced pluripotent stem cells (iPSCs) retain the genetic information of the donor. This confers a remarkable advantage in the study of cellular dysfunction in neurological disease with defined genetic mutations. It is now possible to track pathogenesis in specific neuronal populations in a clinically-relevant genetic context. Optimal application of cellular reprogramming will be largely dependent on the specific features of the disease under investigation. Successful reprogramming of somatic cells to a pluripotent state can be achieved through the transient expression of defined transcription factors. One of the most exciting aspects of this technology is that human neurons generated from these induced pluripotent stem cells (iPSCs) retain the genetic information of the donor. This confers a remarkable advantage in the study of cellular dysfunction in neurological disease with defined genetic mutations. It is now possible to track pathogenesis in specific neuronal populations in a clinically-relevant genetic context. Optimal application of cellular reprogramming will be largely dependent on the specific features of the disease under investigation.
出处 《Frontiers in Biology》 CAS CSCD 2012年第3期F0003-F0003,共1页 生物学前沿(英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部